PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

trazodone Side Effects

The reactions most often reported to the FDA for trazodone (also sold as Desyrel), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

15,113
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of trazodone come from 15,113 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 15,113 reports to the FDA Adverse Event Reporting System (FAERS) for trazodone (Desyrel): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

15,113

Reports Mentioning Death

1,538

10.2% of reports — not proof the medicine caused the death

Hospitalizations

5,063

33.5% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

FATIGUE
1,129
NAUSEA
1,097
HEADACHE
909
PAIN
808
DIARRHOEA
793
VOMITING
676
INSOMNIA
673
DEPRESSION
656
DYSPNOEA
623
DIZZINESS
599
FALL
591
ASTHENIA
519
ANXIETY
512
ARTHRALGIA
472
DEATH
454
MALAISE
425
BACK PAIN
422
CONSTIPATION
413

Who Reports Side Effects

Gender Distribution

Female 9,386 (67%)
Male 4,716 (33%)
Unknown 9

Age Distribution

0-17 185 (2%)
18-44 1,913 (20%)
45-64 3,900 (41%)
65-74 1,719 (18%)
75+ 1,889 (20%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 1,538 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 452
COMPLETED SUICIDE 269
TOXICITY TO VARIOUS AGENTS 155
CARDIO-RESPIRATORY ARREST 118
DRUG ABUSE 97
CARDIAC ARREST 74
VOMITING 65
ASPHYXIA 53
ARTERIOSCLEROSIS CORONARY ARTERY 52
OVERDOSE 52
PNEUMONIA 51
NAUSEA 49
DIARRHOEA 44
DECREASED APPETITE 42
RESPIRATORY ARREST 41
RESPIRATORY FAILURE 37
GENERAL PHYSICAL HEALTH DETERIORATION 36
PAIN 36

Reactions in Hospitalization Reports

Top reactions in 5,063 reports where hospitalization was an outcome.

Reaction Reports
NAUSEA 408
FATIGUE 407
PNEUMONIA 341
HEADACHE 336
DIARRHOEA 334
FALL 322
DYSPNOEA 309
PAIN 284
VOMITING 272
ASTHENIA 262
DEPRESSION 244
PYREXIA 244
HYPERTENSION 215
SUICIDE ATTEMPT 204
INSOMNIA 198
CONSTIPATION 190
DIZZINESS 190
ANXIETY 188

Compare trazodone vs acamprosate →

What the FAERS Data Reveals About trazodone Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 15,113 voluntary reports linked to trazodone and its brand equivalents (Desyrel), spanning 2004 through 2025. Of those, 1,538 (10.2%) listed death as an outcome and 5,063 (33.5%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 67% were female and 33% male; age distribution skews toward 45-64, with 3,900 reports in that bracket. The single most reported reaction is fatigue with 1,129 submissions, followed by nausea and headache.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.